Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens.
about
Dopamine release in the basal gangliaMultiple roles for nicotine in Parkinson's diseaseIn vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptorsCrucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administrationThe neuronal nicotinic acetylcholine receptors alpha 4* and alpha 6* differentially modulate dopamine release in mouse striatal slicesOrthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking CessationLocal control of striatal dopamine releaseNicotinic modulation of glutamate receptor function at nerve terminal level: a fine-tuning of synaptic signalsMolecules and circuits involved in nicotine addiction: The many faces of smokingPreclinical evidence that activation of mesolimbic alpha 6 subunit containing nicotinic acetylcholine receptors supports nicotine addiction phenotypeCharacterization of a Novel -Conotoxin from Conus textile That Selectively Targets 6/ 3 2 3 Nicotinic Acetylcholine ReceptorsMechanistic insights into nicotine withdrawal.Role of Nitric Oxide on Dopamine Release and Morphine-DependencyDopaminergic and cholinergic learning mechanisms in nicotine addictionStable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonistsVarenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatumExpression profile of nicotinic acetylcholine receptor subunits in the brain of HIV-1 transgenic rats given chronic nicotine treatment.Roles for N-terminal extracellular domains of nicotinic acetylcholine receptor (nAChR) β3 subunits in enhanced functional expression of mouse α6β2β3- and α6β4β3-nAChRs.Loss of VGLUT3 Produces Circadian-Dependent Hyperdopaminergia and Ameliorates Motor Dysfunction and l-Dopa-Mediated Dyskinesias in a Model of Parkinson's DiseaseReplicated Risk Nicotinic Cholinergic Receptor Genes for Nicotine Dependence.Nicotine withdrawal.Analysis of rare variations reveals roles of amino acid residues in the N-terminal extracellular domain of nicotinic acetylcholine receptor (nAChR) alpha6 subunit in the functional expression of human alpha6*-nAChRs.Nicotinic receptor-mediated reduction in L-DOPA-induced dyskinesias may occur via desensitizationAlpha-conotoxin MII-sensitive nicotinic acetylcholine receptors in the nucleus accumbens shell regulate progressive ratio responding maintained by nicotine.Comparison of effects produced by nicotine and the α4β2-selective agonist 5-I-A-85380 on intracranial self-stimulation in rats.Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors.Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.Structural differences determine the relative selectivity of nicotinic compounds for native alpha 4 beta 2*-, alpha 6 beta 2*-, alpha 3 beta 4*- and alpha 7-nicotine acetylcholine receptorsStriatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum.Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence.Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens.Progress and challenges in the study of α6-containing nicotinic acetylcholine receptors.Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.The novel α7β2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization.The frequency-dependence of the nicotine-induced inhibition of dopamine is controlled by the α7 nicotinic receptorAge-related changes in dopamine signaling in Nurr1 deficient mice as a model of Parkinson's diseaseAcute ethanol inhibits dopamine release in the nucleus accumbens via α6 nicotinic acetylcholine receptorsSex, ADHD symptoms, and smoking outcomes: an integrative model.Striatal dopamine transmission is subtly modified in human A53Tα-synuclein overexpressing mice.α6ß2* and α4ß2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's disease
P2860
Q22251247-244EC856-605B-4C6E-89B6-19348AF25042Q22252514-617E076D-B4DD-42C0-B2D6-A60DEC3ECE20Q24643170-AE15F625-5A8B-4118-9A52-AC34142B210AQ24650892-80F995BB-5963-4F89-826F-1AC283340B04Q24655429-8FD1BA26-72FC-441F-9DB7-FA4D5932CA94Q26774830-DFF629D8-D855-4EBB-8CF9-9CD5AA1A19D4Q26861838-93B6D10C-7A88-45A0-A76B-50E20310DF28Q26861923-7979A7FC-758E-4920-9443-AEEBA7C4B1A3Q27008063-09F95C07-6AFC-4DEA-928F-A11364E110E4Q27021772-C945463F-138B-4F63-9AB8-4CDB60DA988DQ27675258-6E6B1158-5283-4BAC-8035-5C090DDEDB71Q27687645-3FBA2B89-80FE-48D9-9088-833982CC8467Q28068951-50865C2F-AEA8-40B2-B80E-C5DE2F4D9960Q28084459-710D5825-95E0-4FDF-9157-CC55AA27C2D4Q28388268-0C7998B1-9C3D-45F4-B5A1-68E5B9A76A30Q28576280-115AA30D-8179-42E5-B061-6BD47C64FC18Q30277012-B6BB1EA3-517D-4A0C-8366-7ADD55B1754BQ30370472-61E90275-E29D-4EB3-9B91-273899084A69Q30383888-531C4BEC-1753-46C4-B6F1-7A2B402D7B2CQ30395065-F97389F4-8174-4511-8528-8F41BFDA0D5DQ30404700-B8497336-6845-4200-BA94-0A6F268784DCQ30413058-30048725-216B-4ACB-B8FF-4EEFF18E2AE1Q30475334-C7501D77-52BE-440A-8FCE-70BDDEDCA5D1Q30493138-004A06C1-CF0D-4BD8-9E03-A7C49C0096A7Q30738165-30ABCD2F-0435-4B4F-A49D-284EA27A21F2Q33621205-8D80674A-4079-4F21-9768-FA3E77A166FFQ33738559-31CE3A45-B349-4FF4-86FA-686D184CEDF6Q33770793-3164029B-8442-488C-9E37-0E2CDCAC62A9Q33835219-20F1EB0E-FCBC-4D61-908C-CE2801C38FB1Q33870433-CDD6F10A-34F0-4168-9499-76058F25FEA8Q33929766-078FC7C8-CC52-484B-B449-865790552F9EQ33954007-C7CB4558-3BE9-4B6E-A3A3-83FFCA097760Q33955964-4EEB2AD4-D414-44FE-B239-917D44BEBF30Q34125225-B90CDEDF-8319-49C3-B931-C3E763848EFBQ34154675-32D694A3-BFD1-4B6D-A313-6896A1C43863Q34181259-FB519868-5C97-43C2-B6AD-BA050D7E83CDQ34219378-FE11AE7F-75B2-4DC3-A62B-62DE5CF34DF1Q34255025-9F840506-F559-4BD4-91CC-E83241F5999DQ34263294-3E1E70AF-2F1A-4E24-9350-0C9AB3EB7756Q34309950-79BDF57C-AF25-4DBA-BB42-C32F266B0747
P2860
Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Alpha6-containing nicotinic ac ...... smission in nucleus accumbens.
@ast
Alpha6-containing nicotinic ac ...... smission in nucleus accumbens.
@en
Alpha6-containing nicotinic ac ...... smission in nucleus accumbens.
@nl
type
label
Alpha6-containing nicotinic ac ...... smission in nucleus accumbens.
@ast
Alpha6-containing nicotinic ac ...... smission in nucleus accumbens.
@en
Alpha6-containing nicotinic ac ...... smission in nucleus accumbens.
@nl
prefLabel
Alpha6-containing nicotinic ac ...... smission in nucleus accumbens.
@ast
Alpha6-containing nicotinic ac ...... smission in nucleus accumbens.
@en
Alpha6-containing nicotinic ac ...... smission in nucleus accumbens.
@nl
P2093
P2860
P356
P1476
Alpha6-containing nicotinic ac ...... nsmission in nucleus accumbens
@en
P2093
J Michael McIntosh
Michael A Clements
Richard Exley
P2860
P2888
P304
P356
10.1038/SJ.NPP.1301617
P407
P577
2007-11-21T00:00:00Z
P5875
P6179
1053664732